Nalaganje...
Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis
PURPOSE: With increasing environmental pollution, the incidence of allergic conjunctivitis is increasing. Newer anti-allergic medications with combined anti-histaminic and mast cell stabilization action can help reducing the use of topical steroids for milder form of disease. There is no study direc...
Shranjeno v:
| izdano v: | Indian J Ophthalmol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer - Medknow
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6727736/ https://ncbi.nlm.nih.gov/pubmed/31436181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijo.IJO_2112_18 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|